$47.22
+1.07 (+2.32%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+28.56%
1Y
+72.52%
YTD
+11.39%
Open$47.00
Previous Close$46.15
Day High$47.80
Day Low$46.21
52W High$60.91
52W Low$23.79
Volume—
Avg Volume1.67M
Market Cap3.71B
P/E Ratio32.41
EPS$1.40
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$40.85
Above
SMA 200
$34.09
Above
RSI (14)
37.6
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
18 analysts
Price Target
-0.8% upside
Current
$47.22
$47.22
Target
$46.85
$46.85
$30.44
$46.85 avg
$57.64
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 504.28M | 418.94M | 507.99M |
| Net Income | 64.70M | 48.38M | -2,027,984 |
| Profit Margin | 12.8% | 12.2% | -0.4% |
| EBITDA | 64.05M | 50.55M | -2,983,128 |
| Free Cash Flow | — | — | -1,866,923 |
| Rev Growth | +20.4% | +20.4% | +16.6% |
| Debt/Equity | — | — | 0.52 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $246.04 | +0.89% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $410.95 | +1.51% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $133.21 | +1.80% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $496.07 | +2.49% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $784.36 | +1.59% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.20 | +1.43% | 35.2 | 28.41B |